These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device. Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137 [TBL] [Abstract][Full Text] [Related]
5. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. Hayward C; Adachi I; Baudart S; Davis E; Feller ED; Kinugawa K; Klein L; Li S; Lorts A; Mahr C; Mathew J; Morshuis M; Müller M; Ono M; Pagani FD; Pappalardo F; Rich J; Robson D; Rosenthal DN; Saeed D; Salerno C; Sauer AJ; Schlöglhofer T; Tops L; VanderPluym C J Thorac Cardiovasc Surg; 2022 Oct; 164(4):1120-1137.e2. PubMed ID: 35624053 [TBL] [Abstract][Full Text] [Related]
6. HVAD to Heartmate 3 Device Exchange: A Society of Thoracic Surgeons Intermacs Analysis. Cogswell R; Cantor RS; Vorovich E; Kilic A; Stehlik J; Cowger JA; Habib RH; Kirklin JK; Pagani FD; Atluri P Ann Thorac Surg; 2022 Nov; 114(5):1672-1678. PubMed ID: 34678286 [TBL] [Abstract][Full Text] [Related]
7. Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience. Agarwal R; Kyvernitakis A; Soleimani B; Milano CA; Davis RP; Kennedy JL; Yarboro L; Benza RL; Moraca RJ; Bailey SH Ann Thorac Surg; 2019 Oct; 108(4):1178-1182. PubMed ID: 31059685 [TBL] [Abstract][Full Text] [Related]
8. Graft Resistance Difference after HVAD to HeartMate 3 Left Ventricular Assist Device Exchange. Bourque K; Martin MJ; Harjes DI; Cassidy DL; Pagani FD; Kormos RL Ann Thorac Surg; 2022 Dec; 114(6):2226-2233. PubMed ID: 34990572 [TBL] [Abstract][Full Text] [Related]
9. Widening care gap in VAD therapy. Conway J; Amdani S; Morales DLS; Lorts A; Rosenthal DN; Jacobs JP; Rossano J; Koehl D; Kirklin JK; Auerbach SR J Heart Lung Transplant; 2023 Dec; 42(12):1710-1724. PubMed ID: 37591455 [TBL] [Abstract][Full Text] [Related]
10. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II? Florisson DS; Conte SM; De Bono JA; Newcomb AE Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825 [TBL] [Abstract][Full Text] [Related]
11. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices. Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964 [TBL] [Abstract][Full Text] [Related]
13. Thrombus on the inflow cannula of the HeartWare HVAD: an update. Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526 [TBL] [Abstract][Full Text] [Related]
14. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices. Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028 [TBL] [Abstract][Full Text] [Related]
15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
16. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support. Numan L; Ramjankhan FZ; Oberski DL; Oerlemans MIFJ; Aarts E; Gianoli M; Van Der Heijden JJ; De Jonge N; Van Der Kaaij NP; Meuwese CL; Mokhles MM; Oppelaar AM; De Waal EEC; Asselbergs FW; Van Laake LW ESC Heart Fail; 2021 Apr; 8(2):1596-1603. PubMed ID: 33635573 [TBL] [Abstract][Full Text] [Related]
17. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps. Zhang J; Chen Z; Griffith BP; Wu ZJ Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405 [TBL] [Abstract][Full Text] [Related]
18. HeartWare to HeartMate 3 left ventricular assist device exchange via a left lateral thoracotomy. Nersesian G; Montagner M; Lanmueller P; Lewin D; Van Praet KM; Kofler M; Ott S; Falk V; Potapov E Multimed Man Cardiothorac Surg; 2022 Dec; 2022():. PubMed ID: 36476648 [TBL] [Abstract][Full Text] [Related]
19. Device exchange from Heartmate II to HeartWare HVAD. Beaupre RA; Alnajar A; Sugiura T; Chou B; Lamba HK; Kurihara C; Kawabori M; Critsinelis AC; Santiago A; Morgan JA J Card Surg; 2019 Nov; 34(11):1204-1207. PubMed ID: 31478230 [TBL] [Abstract][Full Text] [Related]
20. Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump. Kormos RL; McCall M; Althouse A; Lagazzi L; Schaub R; Kormos MA; Zaldonis JA; Sciortino C; Lockard K; Kuntz N; Dunn E; Teuteberg JJ Circulation; 2017 Oct; 136(18):1714-1725. PubMed ID: 28674109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]